Instituto de Investigaciones Clinicas de Quilmes

Quilmes B1878GEG

0 studies enrolling now · 3 studies all time

What they study most

Hypertension, Lupus Erythematosus, Systemic

Studies at this site

• A Study to Evaluate the Efficacy and Safety of CC-220 in Subjects With Active Systemic Lupus Erythematosus — Completed
• DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant Hypertension — Completed
• DORADO-AC-EX - A Long-Term Safety Extension Study to the Phase 3 DORADOC-AC Study (Protocol DAR-312) of Darusentan in Resistant Hypertension — Stopped early